Entero Regains Nasdaq Compliance With Grid AI Acquisition
SCS
0.0200
The Fort Worth Press - Entero Regains Nasdaq Compliance With Grid AI Acquisition
USD
-
AED 3.672503
AFN 66.000343
ALL 81.750787
AMD 378.260319
ANG 1.79008
AOA 917.000119
ARS 1447.7807
AUD 1.429327
AWG 1.80125
AZN 1.695576
BAM 1.65515
BBD 2.013067
BDT 122.134821
BGN 1.67937
BHD 0.37701
BIF 2960
BMD 1
BND 1.271532
BOB 6.906503
BRL 5.2395
BSD 0.999467
BTN 90.452257
BWP 13.162215
BYN 2.854157
BYR 19600
BZD 2.010138
CAD 1.366615
CDF 2225.000441
CHF 0.777305
CLF 0.021735
CLP 858.210238
CNY 6.938199
CNH 6.93926
COP 3628.58
CRC 495.478914
CUC 1
CUP 26.5
CVE 93.31088
CZK 20.654396
DJF 177.720153
DKK 6.328325
DOP 62.700992
DZD 129.716681
EGP 46.898171
ERN 15
ETB 154.846992
EUR 0.84738
FJD 2.20515
FKP 0.729917
GBP 0.73281
GEL 2.695017
GGP 0.729917
GHS 10.974578
GIP 0.729917
GMD 72.999681
GNF 8771.298855
GTQ 7.666172
GYD 209.107681
HKD 7.812425
HNL 26.40652
HRK 6.385502
HTG 131.004367
HUF 321.707506
IDR 16807
ILS 3.094805
IMP 0.729917
INR 90.44185
IQD 1309.366643
IRR 42125.000158
ISK 122.698337
JEP 0.729917
JMD 156.730659
JOD 0.709031
JPY 156.945499
KES 128.949615
KGS 87.449748
KHR 4034.223621
KMF 418.00016
KPW 899.945137
KRW 1461.704465
KWD 0.30733
KYD 0.83291
KZT 496.518171
LAK 21498.933685
LBP 89504.332961
LKR 309.337937
LRD 185.901857
LSL 15.973208
LTL 2.95274
LVL 0.604889
LYD 6.316351
MAD 9.162679
MDL 16.911242
MGA 4427.744491
MKD 52.212764
MMK 2099.936125
MNT 3569.846682
MOP 8.043143
MRU 39.687396
MUR 45.879676
MVR 15.450132
MWK 1732.791809
MXN 17.32615
MYR 3.935502
MZN 63.749926
NAD 15.973816
NGN 1368.559885
NIO 36.779547
NOK 9.67647
NPR 144.74967
NZD 1.666655
OMR 0.384458
PAB 0.999458
PEN 3.359892
PGK 4.282021
PHP 58.951022
PKR 279.546749
PLN 3.57428
PYG 6615.13009
QAR 3.645472
RON 4.317499
RSD 99.475027
RUB 76.246155
RWF 1458.735317
SAR 3.75002
SBD 8.058101
SCR 13.714455
SDG 601.498038
SEK 8.989675
SGD 1.27291
SHP 0.750259
SLE 24.474968
SLL 20969.499267
SOS 570.224434
SRD 37.894053
STD 20697.981008
STN 20.734071
SVC 8.745065
SYP 11059.574895
SZL 15.972716
THB 31.719961
TJS 9.340239
TMT 3.51
TND 2.890703
TOP 2.40776
TRY 43.529499
TTD 6.770395
TWD 31.672103
TZS 2580.289652
UAH 43.116413
UGX 3558.598395
UYU 38.520938
UZS 12251.99609
VES 371.640565
VND 25982
VUV 119.556789
WST 2.72617
XAF 555.124234
XAG 0.011178
XAU 0.0002
XCD 2.70255
XCG 1.80131
XDR 0.68948
XOF 555.135979
XPF 100.927097
YER 238.374961
ZAR 16.080355
ZMK 9001.194249
ZMW 19.565181
ZWL 321.999592
- Stocks in retreat as traders reconsider tech investment
- LA officials call for Olympic chief to resign over Epstein file emails
- Ukraine, Russia, US to start second day of war talks
- Fiji football legend returns home to captain first pro club
- Trump attacks US electoral system with call to 'nationalize' voting
- Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
- US households become increasingly strained in diverging economy
- Four dead men: the cold case that engulfed a Colombian cycling star
- Super Bowl stars stake claims for Olympic flag football
- On a roll, Brazilian cinema seizes its moment
Entero Regains Nasdaq Compliance With Grid AI Acquisition
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule").
Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid‑edge orchestration, and AI‑driven infrastructure optimization.
Forward‑Looking Statements
This press release contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the strategic benefits of the acquisition, the integration of Grid AI, the ability to maintain compliance with Nasdaq's listing criteria in connection with the Grid AI acquisition and otherwise, the ability to obtain shareholder approval of the common stock underlying the preferred stock issued in the Grid AI acquisition, expected future operating results, market opportunities, and the Company's growth strategy. Actual results may differ materially due to risks and uncertainties. The Company undertakes no obligation to update forward‑looking statements except as required by law.
About Entero Therapeutics, Inc.
Entero Therapeutics (NASDAQ:ENTO) is a publicly listed company. The Company's programs address significant unmet needs in gastrointestinal (GI) health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid AI, the Company is continuing these prior operations and is also repositioning into the infrastructure, AI and data‑centre orchestration space. Entero operates Grid AI as a wholly‑owned subsidiary and intends to leverage its public‑market listing and corporate resources to scale the new venture.
About Grid AI
Grid AI is an AI‑driven, grid‑edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, DERs and compute assets. The platform supports major ML frameworks, offers rapid scale across cloud GPU/CPU infrastructure, and is designed to deliver SaaS‑like recurring revenue.
Investor & Media Contacts:
Entero Investor Relations
[email protected]
SOURCE: Entero Therapeutics, Inc.
View the original press release on ACCESS Newswire
L.Holland--TFWP
